In Follow-up
Cancer Types
Locations
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | WA
PROTOCOL #
ANZUP 2101
ANZadapt
Phase II randomised controlled trial of patient-specific adaptive versus continuous Abiraterone or eNZalutamide in metastatic castration-resistant prostate cancer
Trial assessing whether adaptive (pause–restart) hormone treatment compared to continuous hormone treatment improves outcomes for people with advanced…
TYPE
Bladder
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | WA | UK
PROTOCOL #
ANZUP 1301
TYPE
Testicular
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | NZ
PROTOCOL #
ANZUP1906
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | TAS | WA | NZ | Ireland | Canada | USA
PROTOCOL #
ANZUP 1801
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | WA
PROTOCOL #
ANZUP 1901
ENZA-p
A randomised phase II trial using PSMA as a therapeutic agent and prognostic indicator in people with metastatic castration-resistant prostate cancer treated with enzalutamide.
Trial assessing whether adding a targeted radiation treatment (LuPSMA) to enzalutamide improves outcomes, and how PSMA PET/CT can help monitor disease…
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | NT | SA | TAS | WA | NZ | UK | Ireland | Canada | USA
PROTOCOL #
ANZUP 1304
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | TAS | WA | NZ | UK | Ireland | Belgium | USA | Spain | Austria | Slovenia
PROTOCOL #
ANZUP 1303
ENZARAD
Enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer: a randomised phase III trial
Trial assessing whether adding enzalutamide to standard hormone therapy and radiation improves survival and quality of life for people with high-risk …
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | SA | WA
PROTOCOL #
ANZUP 2001
EVOLUTION
Phase II Study of Radionuclide 177Lu-PSMA Therapy versus 177Lu-PSMA in Combination with Ipilimumab and Nivolumab for people with Metastatic Castration Resistant Prostate Cancer
Trial assessing whether adding immunotherapy (ipilimumab and nivolumab) to a targeted radiation treatment (LuPSMA) improves outcomes for people with a…
TYPE
Bladder
STATUS
In Follow-up
LOCATION
WA
PROTOCOL #
ANZUP 2403
G-DISCO
A Phase 1 study of feasibility, safety and tolerability of synchronous intravesical administration of gemcitabine and docetaxel
Early-phase trial testing whether giving two chemotherapy treatments (gemcitabine and docetaxel) directly into the bladder together is safe and well tolerated for people with bladder cancer.
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | WA
PROTOCOL #
HREC/16/PMCC/130
proPSMA
A prospective randomised multi-centre study of the impact of Ga-68 PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy
Trial evaluating whether PSMA PET/CT scans can better detect cancer spread that may not be seen on standard scans and improve treatment decisions for …
TYPE
Kidney
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA
PROTOCOL #
ANZUP 1606
RAMPART
Renal Adjuvant MultiPle Arm Randomised Trial (RAMPART): An international investigator-led phase III multi arm multi stage multi-centre randomised cont…
Trial assessing whether immunotherapy (durvalumab with or without tremelimumab) after kidney cancer surgery can reduce the chance of the cancer returning.
TYPE
Testicular
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | International
PROTOCOL #
ANZUP 1604
TIGER
A Randomised Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy Us…
Trial assessing whether more intensive chemotherapy with a stem cell transplant is more effective than standard chemotherapy for people with testicula…